Skip to main content
Top
Published in: BMC Neurology 1/2016

Open Access 01-12-2016 | Research article

The effects of a mindfulness-based lifestyle program for adults with Parkinson’s disease: a mixed methods, wait list controlled randomised control study

Authors: Jenny Advocat, Joanne Enticott, Brooke Vandenberg, Craig Hassed, Jennifer Hester, Grant Russell

Published in: BMC Neurology | Issue 1/2016

Login to get access

Abstract

Background

Parkinson’s disease (PD) is the second commonest neurodegenerative disease in developed countries. Current treatment for PD is pharmacologically focused and can have significant side-effects. There is increasing interest in holistic approaches including mindfulness to help manage the challenges associated with living with PD. We hypothesised that there would be an improvement in PD associated function and wellbeing in participants after participating in a 6-week mindfulness-based lifestyle program, and that these improvements would be sustainable at 6 months. Our primary objective was to determine changes in function and wellbeing associated with PD.

Methods

An exploratory prospective, mixed-method, randomised control trial incorporating a before and after design with a waitlist control, with an embedded qualitative component was conducted in 2012–2013. Participants included community living adults with disability congruent to H&Y Stage 2 PD, aged 18–75, fluent in spoken and written English and able to attend at least four of six sessions of the program. Participants were randomised to the intervention or wait-list control groups at two locations. All participants in the wait-list control group eventually received the intervention. Two randomisation codes were created for each location. Allocation to the intervention or wait-list control was by random number generation. The program facilitator and participants were blinded to participant data.

Results

Group 1 included 35 participants and group 2 (the waitlist control), 37. Data was analysed from 24 (group 1) and 33 (group 2) participants. The intervention group, compared to the waitlist control, showed a small improvement in function and wellbeing associated with PD immediately after the program (t-score = −0.59) and at 6-month post intervention (t-score = −1.42) as reported by the PDQ-39 SI. However this finding was not significant (p = 0.56 and 0.16 respectively). A small yet significant effect size (β = 0.23) in PDQ-39 ADL was reported in group 1 after 6-months post-intervention. This showed a positive improvement in the ADL as reported by group 1 after 6-months (t-score −1.8, p = 0.04). Four secondary measures are reported.

Conclusions

Our findings suggest mindfulness-based lifestyle programs have potential to assist participants in managing the ongoing difficulties associated with a neurological condition such as Parkinson’s disease. Importantly, our study shows promise for the long term benefits of such programs. Improvements to participant activities in daily living and mindfulness were retained at 6-months post intervention. A more definitive study should be conducted in a larger sample of PD patients to further explore these findings and their impact on reducing stress and anxiety in PD patients.

Trial Registration

Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12612000440​820, 17th April 2012.
Literature
2.
go back to reference World Health Organization. Neurological disorders: a public health approach (Dementia, Epilepsy, Headache disorders, Multiple sclerosis, Neuroinfections). In: World Health Organization. Neurological disorders: public health challenges. Geneva: WHO Press; 2006. p. 41–110. World Health Organization. Neurological disorders: a public health approach (Dementia, Epilepsy, Headache disorders, Multiple sclerosis, Neuroinfections). In: World Health Organization. Neurological disorders: public health challenges. Geneva: WHO Press; 2006. p. 41–110.
4.
go back to reference Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–90.CrossRefPubMed Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–90.CrossRefPubMed
5.
go back to reference Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157(11):1015–22.CrossRef Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157(11):1015–22.CrossRef
6.
go back to reference Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord. 2009;24(11):1641–9.CrossRefPubMed Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord. 2009;24(11):1641–9.CrossRefPubMed
7.
go back to reference Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiver-burden in Parkinson's disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord. 2006;12(1):35–41.CrossRefPubMed Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiver-burden in Parkinson's disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord. 2006;12(1):35–41.CrossRefPubMed
8.
go back to reference Ott MJ, Norris RL, Bauer-Wu SM. Mindfulness meditation for oncology patients: a discussion and critical review. Integr Cancer Ther. 2006;5(2):98–108.CrossRefPubMed Ott MJ, Norris RL, Bauer-Wu SM. Mindfulness meditation for oncology patients: a discussion and critical review. Integr Cancer Ther. 2006;5(2):98–108.CrossRefPubMed
9.
go back to reference Grossman P, Tiefenthaler-Gilmer U, Raysz A, Kesper U. Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychother Psychosom. 2007;76(4):226–33.CrossRefPubMed Grossman P, Tiefenthaler-Gilmer U, Raysz A, Kesper U. Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychother Psychosom. 2007;76(4):226–33.CrossRefPubMed
10.
go back to reference Pradhan EK, Baumgarten M, Langenberg P, Handwerger B, Gilpin AK, Magyari T, et al. Effect of mindfulness-based stress reduction in rheumatoid arthritis patients. Arthritis Rheum. 2007;57(7):1134–42.CrossRefPubMed Pradhan EK, Baumgarten M, Langenberg P, Handwerger B, Gilpin AK, Magyari T, et al. Effect of mindfulness-based stress reduction in rheumatoid arthritis patients. Arthritis Rheum. 2007;57(7):1134–42.CrossRefPubMed
11.
go back to reference Morone NE, Greco CM, Weiner DK. Mindfulness meditation for the treatment of chronic low back pain in older adults: a randomized controlled pilot study. Pain. 2008;134(3):310–9.CrossRefPubMed Morone NE, Greco CM, Weiner DK. Mindfulness meditation for the treatment of chronic low back pain in older adults: a randomized controlled pilot study. Pain. 2008;134(3):310–9.CrossRefPubMed
12.
go back to reference Bohlmeijer E, Prenger R, Taal E, Cuijpers P. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. J Psychosom Res. 2010;68(6):539–44.CrossRefPubMed Bohlmeijer E, Prenger R, Taal E, Cuijpers P. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. J Psychosom Res. 2010;68(6):539–44.CrossRefPubMed
13.
go back to reference Grossman P, Kappos L, Gensicke H, D'Souza M, Mohr DC, Penner IK, et al. MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology. 2010;75(13):1141–9.CrossRefPubMedPubMedCentral Grossman P, Kappos L, Gensicke H, D'Souza M, Mohr DC, Penner IK, et al. MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology. 2010;75(13):1141–9.CrossRefPubMedPubMedCentral
14.
go back to reference Jelinek G, Hassed C. Managing multiple sclerosis in primary care: are we forgetting something? Qual Prim Care. 2009;17(1):55–61.PubMed Jelinek G, Hassed C. Managing multiple sclerosis in primary care: are we forgetting something? Qual Prim Care. 2009;17(1):55–61.PubMed
15.
go back to reference Kabat-Zinn J, Wheeler E, Light T, Skillings A, Scharf MJ, Cropley TG, et al. Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom Med. 1998;60(5):625–32.CrossRefPubMed Kabat-Zinn J, Wheeler E, Light T, Skillings A, Scharf MJ, Cropley TG, et al. Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom Med. 1998;60(5):625–32.CrossRefPubMed
16.
go back to reference Hadgkiss EJ, Jelinek GA, Weiland TJ, Rumbold G, Mackinlay CA, Gutbrod S, et al. Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis. J Neurol Sci. 2013;34(2):187–95.CrossRef Hadgkiss EJ, Jelinek GA, Weiland TJ, Rumbold G, Mackinlay CA, Gutbrod S, et al. Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis. J Neurol Sci. 2013;34(2):187–95.CrossRef
17.
go back to reference Pickut BA, Vanneste S, Hirsch MA, Van Heck W, Kerckhofs E, Marien P, et al. Mindfulness training among individuals with Parkinson's disease: neurobehavioral effects. J Parkinsons Dis. 2015;2015:1–6.CrossRef Pickut BA, Vanneste S, Hirsch MA, Van Heck W, Kerckhofs E, Marien P, et al. Mindfulness training among individuals with Parkinson's disease: neurobehavioral effects. J Parkinsons Dis. 2015;2015:1–6.CrossRef
18.
go back to reference Fitzpatrick L, Simpson J, Smith A. A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson's disease. Psychol Psychother-T. 2010;83:179–92.CrossRef Fitzpatrick L, Simpson J, Smith A. A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson's disease. Psychol Psychother-T. 2010;83:179–92.CrossRef
19.
20.
go back to reference Advocat J, Russell G, Enticott J, Hassed C, Hester J, Vandenberg B. The effects of a mindfulness-based lifestyle programme for adults with Parkinson’s disease: protocol for a mixed methods, randomised two-group control study. BMJ Open. 2013;3(10), e003326.CrossRefPubMedPubMedCentral Advocat J, Russell G, Enticott J, Hassed C, Hester J, Vandenberg B. The effects of a mindfulness-based lifestyle programme for adults with Parkinson’s disease: protocol for a mixed methods, randomised two-group control study. BMJ Open. 2013;3(10), e003326.CrossRefPubMedPubMedCentral
24.
go back to reference Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26:353–7.CrossRefPubMed Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26:353–7.CrossRefPubMed
25.
go back to reference Walach H, Buchheld N, Buttenmüller V, Kleinknecht N, Schmidt S. Measuring mindfulness-the Freiburg Mindfulness Inventory (FMI). Pers Indivd Dif. 2006;40:1543–55.CrossRef Walach H, Buchheld N, Buttenmüller V, Kleinknecht N, Schmidt S. Measuring mindfulness-the Freiburg Mindfulness Inventory (FMI). Pers Indivd Dif. 2006;40:1543–55.CrossRef
26.
go back to reference Lovibond S, Lovibond P. Manual for the depression anxiety stress scales. 2nd ed. Sydney: Psychology Foundation; 1995. Lovibond S, Lovibond P. Manual for the depression anxiety stress scales. 2nd ed. Sydney: Psychology Foundation; 1995.
27.
go back to reference Wallston KA. The validity of the multidimensional health locus of control scales. J Health Psychol. 2005;10(5):623–31.CrossRefPubMed Wallston KA. The validity of the multidimensional health locus of control scales. J Health Psychol. 2005;10(5):623–31.CrossRefPubMed
30.
go back to reference Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Earlbaum Associates; 1988. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Earlbaum Associates; 1988.
31.
go back to reference Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335–43.CrossRefPubMed Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335–43.CrossRefPubMed
32.
go back to reference Mohr B, Müller V, Mattes R, Rosin R, Federmann B, Strehl U, et al. Behavioral treatment of Parkinson's disease leads to improvement of motor skills and to tremor reduction. Behav Ther. 1996;27(2):235–55.CrossRef Mohr B, Müller V, Mattes R, Rosin R, Federmann B, Strehl U, et al. Behavioral treatment of Parkinson's disease leads to improvement of motor skills and to tremor reduction. Behav Ther. 1996;27(2):235–55.CrossRef
33.
go back to reference Payne JA. Group learning for adults with disabilities or chronic disease. Rehabil Nurs. 1995;20(5):268–72.CrossRefPubMed Payne JA. Group learning for adults with disabilities or chronic disease. Rehabil Nurs. 1995;20(5):268–72.CrossRefPubMed
34.
go back to reference Schreurs KMG, De Ridder DTD, Bensing JM. A one year study of coping, social support and quality of life in parkinson's disease. Psychol Health. 2000;15(1):109–21.CrossRef Schreurs KMG, De Ridder DTD, Bensing JM. A one year study of coping, social support and quality of life in parkinson's disease. Psychol Health. 2000;15(1):109–21.CrossRef
35.
go back to reference Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson’s disease (2001): treatment guidelines. Neurology. 2001;56 suppl 5:S1–88.CrossRefPubMed Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson’s disease (2001): treatment guidelines. Neurology. 2001;56 suppl 5:S1–88.CrossRefPubMed
36.
go back to reference Cairns V, Murray C. How do the features of mindfulness-based cognitive therapy contribute to positive therapeutic change? A Meta-synthesis of qualitative studies. Behav Cogn Psychoth. 2015;43(03):342–59.CrossRef Cairns V, Murray C. How do the features of mindfulness-based cognitive therapy contribute to positive therapeutic change? A Meta-synthesis of qualitative studies. Behav Cogn Psychoth. 2015;43(03):342–59.CrossRef
37.
go back to reference Bega D, Zadikoff C. Complementary & alternative management of Parkinson’s disease: an evidence-based review of eastern influenced practices. J Mov Disord. 2014;7(2):57–66.CrossRefPubMedPubMedCentral Bega D, Zadikoff C. Complementary & alternative management of Parkinson’s disease: an evidence-based review of eastern influenced practices. J Mov Disord. 2014;7(2):57–66.CrossRefPubMedPubMedCentral
38.
go back to reference Gruber-Baldini AL, Ye J, Anderson KE, Shulman LM. Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson's disease. Parkinsonism Rel Disord. 2009;15(9):665–9.CrossRef Gruber-Baldini AL, Ye J, Anderson KE, Shulman LM. Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson's disease. Parkinsonism Rel Disord. 2009;15(9):665–9.CrossRef
39.
go back to reference Tang YY, Holzel BK, Posner MI. The neuroscience of mindfulness meditation. Nat Rev Neurosci. 2015;16(4):213–25.CrossRefPubMed Tang YY, Holzel BK, Posner MI. The neuroscience of mindfulness meditation. Nat Rev Neurosci. 2015;16(4):213–25.CrossRefPubMed
40.
go back to reference Pickut BA, Van Hecke W, Kerckhofs E, Marien P, Vanneste S, Cras P, et al. Mindfulness based intervention in Parkinson's disease leads to structural brain changes on MRI: a randomized controlled longitudinal trial. Clin Neurol Neurosurg. 2013;115(12):2419–25.CrossRefPubMed Pickut BA, Van Hecke W, Kerckhofs E, Marien P, Vanneste S, Cras P, et al. Mindfulness based intervention in Parkinson's disease leads to structural brain changes on MRI: a randomized controlled longitudinal trial. Clin Neurol Neurosurg. 2013;115(12):2419–25.CrossRefPubMed
41.
go back to reference Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol. 2004;72(1):31–40.CrossRefPubMed Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol. 2004;72(1):31–40.CrossRefPubMed
42.
go back to reference Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. J Psychosom Res. 2004;57(1):35–43.CrossRefPubMed Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. J Psychosom Res. 2004;57(1):35–43.CrossRefPubMed
43.
go back to reference Allen NB, Chambers R, Knight W. Mindfulness-based psychotherapies: a review of conceptual foundations, empirical evidence and practical considerations. Aus NZ J Psychiatry. 2006;40(4):285–94.CrossRef Allen NB, Chambers R, Knight W. Mindfulness-based psychotherapies: a review of conceptual foundations, empirical evidence and practical considerations. Aus NZ J Psychiatry. 2006;40(4):285–94.CrossRef
44.
go back to reference Souza RG, Borges V, Silva SMCdA, Ferraz HB. Quality of life scale in parkinson's disease PDQ-39 - (Brazilian Portuguese version) to assess patients with and without levodopa motor fluctuation. Arq Neuropsiquiatr. 2007;65:787–91.CrossRefPubMed Souza RG, Borges V, Silva SMCdA, Ferraz HB. Quality of life scale in parkinson's disease PDQ-39 - (Brazilian Portuguese version) to assess patients with and without levodopa motor fluctuation. Arq Neuropsiquiatr. 2007;65:787–91.CrossRefPubMed
46.
go back to reference Murman DL. Early treatment of Parkinson's disease: opportunities for managed care. Am J Manag Care. 2012;18(7 Suppl):S183–8.PubMed Murman DL. Early treatment of Parkinson's disease: opportunities for managed care. Am J Manag Care. 2012;18(7 Suppl):S183–8.PubMed
47.
go back to reference Crane C, Crane RS, Eames C, Fennell MJV, Silverton S, Williams JMG, et al. The effects of amount of home meditation practice in mindfulness based cognitive therapy on hazard of relapse to depression in the Staying Well after Depression Trial. Behav Res Ther. 2014;63:17–24.CrossRefPubMedPubMedCentral Crane C, Crane RS, Eames C, Fennell MJV, Silverton S, Williams JMG, et al. The effects of amount of home meditation practice in mindfulness based cognitive therapy on hazard of relapse to depression in the Staying Well after Depression Trial. Behav Res Ther. 2014;63:17–24.CrossRefPubMedPubMedCentral
48.
go back to reference Nyklicek I, Kuijpers KF. Effects of mindfulness-based stress reduction intervention on psychological well-being and quality of life: is increased mindfulness indeed the mechanism? Ann Behav Med. 2008;35(3):331–40.CrossRefPubMedPubMedCentral Nyklicek I, Kuijpers KF. Effects of mindfulness-based stress reduction intervention on psychological well-being and quality of life: is increased mindfulness indeed the mechanism? Ann Behav Med. 2008;35(3):331–40.CrossRefPubMedPubMedCentral
49.
go back to reference Carmody J, Baer RA. Relationships between mindfulness practice and levels of mindfulness, medical and psychological symptoms and well-being in a mindfulness-based stress reduction program. J Behav Med. 2008;31(1):23–33.CrossRefPubMed Carmody J, Baer RA. Relationships between mindfulness practice and levels of mindfulness, medical and psychological symptoms and well-being in a mindfulness-based stress reduction program. J Behav Med. 2008;31(1):23–33.CrossRefPubMed
50.
go back to reference Cash T, Ekouevi V, Kilbourn C, Lageman S. Pilot study of a mindfulness-based group intervention for individuals with Parkinson’s disease and their caregivers. Mindfulness. 2015;7(2):361–71.CrossRef Cash T, Ekouevi V, Kilbourn C, Lageman S. Pilot study of a mindfulness-based group intervention for individuals with Parkinson’s disease and their caregivers. Mindfulness. 2015;7(2):361–71.CrossRef
52.
go back to reference Jenkinson C, Fitzpatrick R, Peto V, Harris R, Saunders P. The Parkinson's disease questionaire: PDQ-39 user manual. Oxford: Health Services Research Unit, University of Oxford; 2008. Jenkinson C, Fitzpatrick R, Peto V, Harris R, Saunders P. The Parkinson's disease questionaire: PDQ-39 user manual. Oxford: Health Services Research Unit, University of Oxford; 2008.
53.
go back to reference Kim M, Dahlberg A, Hagell P. Respondent burden and patient-perceived validity of the PDQ-39. Acta Neurol Scand. 2006;113:132–7.CrossRefPubMed Kim M, Dahlberg A, Hagell P. Respondent burden and patient-perceived validity of the PDQ-39. Acta Neurol Scand. 2006;113:132–7.CrossRefPubMed
54.
go back to reference Johnson AR, Lawrence BJ, Corti EJ, Booth L, Gasson N, Thomas MG, et al. Suitability of the Depression, Anxiety, and Stress Scale in Parkinson’s disease. J Parkinsons Dis. 2016. doi:10.3233/JPD-160842. 1–8.PubMed Johnson AR, Lawrence BJ, Corti EJ, Booth L, Gasson N, Thomas MG, et al. Suitability of the Depression, Anxiety, and Stress Scale in Parkinson’s disease. J Parkinsons Dis. 2016. doi:10.​3233/​JPD-160842. 1–8.PubMed
Metadata
Title
The effects of a mindfulness-based lifestyle program for adults with Parkinson’s disease: a mixed methods, wait list controlled randomised control study
Authors
Jenny Advocat
Joanne Enticott
Brooke Vandenberg
Craig Hassed
Jennifer Hester
Grant Russell
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2016
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-016-0685-1

Other articles of this Issue 1/2016

BMC Neurology 1/2016 Go to the issue